$244.540
-6.382 (-2.61%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de JAZZ por análisis de gráficos similares
Alphio's JAZZ stock price prediction model matches the current Jazz Pharmaceuticals PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $245.66 (+0.46%). The 1-week path is $242.61 (-0.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Jazz Pharmaceuticals PLC?
Jazz Pharmaceuticals appears to be a good buy right now due to its strong growth potential driven by the recent FDA approval of Ziihera, which has increased peak sales forecasts to $3B-$5B. The current price of $244.54 is well below the average analyst price target of $299, suggesting significant upside potential. Additionally, the company's gross margin has improved to 76.30% in Q2 2026, indicating strong profitability. However, the main risk is the negative earnings per share of -1.52 in Q1 2025, which highlights past volatility in earnings.
JAZZ cerró en $244.54 el Friday, tras bajar -2.61%
Jazz Pharmaceuticals PLC (JAZZ) last closed at $244.54, losing -2.61%. These facts feed the 1-day and 1-week JAZZ price prediction above.
Consenso de analistas
Jazz Pharmaceuticals PLC (JAZZ): 16 comprar, 5 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Jazz Pharmaceuticals PLC (JAZZ) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de JAZZ, ordenadas por similitud.
Análisis de estacionalidad de JAZZ
Historically the probability of a positive August return for JAZZ is 39.68%. March offers the highest probability of a positive month at 66.67%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de JAZZ
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $117.15 | $125.23 | $139.00 | -48.79% |
| Sep 2026 | $92.51 | $105.88 | $122.93 | -56.70% |
| Oct 2026 | $99.24 | $112.04 | $117.58 | -54.18% |
| Nov 2026 | $104.10 | $108.47 | $114.97 | -55.64% |
| Dec 2026 | $78.69 | $95.48 | $101.77 | -60.95% |
En 2026, se proyecta que Jazz Pharmaceuticals PLC (JAZZ) oscile entre $78.69 y $139.00.
Previsión mensual de Jazz Pharmaceuticals PLC para 2026
En Aug de 2026, se proyecta que Jazz Pharmaceuticals PLC promedie $125.23, con un mínimo de $117.15 y un máximo de $139.00.
En Sep de 2026, se proyecta que Jazz Pharmaceuticals PLC promedie $105.88, con un mínimo de $92.51 y un máximo de $122.93.
En Oct de 2026, se proyecta que Jazz Pharmaceuticals PLC promedie $112.04, con un mínimo de $99.24 y un máximo de $117.58.
En Nov de 2026, se proyecta que Jazz Pharmaceuticals PLC promedie $108.47, con un mínimo de $104.10 y un máximo de $114.97.
En Dec de 2026, se proyecta que Jazz Pharmaceuticals PLC promedie $95.48, con un mínimo de $78.69 y un máximo de $101.77.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.